PDF(Pubmed)
Abstract：
Sarcoidosis is a multisystem granulomatous disease of an unknown aetiology. It can exist in many organs. Pulmonary and intrathoracic lymph nodes are most commonly involved. Lung sarcoidosis is uncommon in Asia. However, due to the large population of our country and the development of bronchoscopy, percutaneous lung puncture, and other medical technologies, the number of pulmonary sarcoidosis patients is on the rise. Pulmonary sarcoidosis patients have no obvious symptoms in the early stage, and the clinical manifestations in the later stage may vary from person to person. Eventually, the disease progresses to life-threatening pulmonary fibrosis. Therefore, patients with pulmonary sarcoidosis should receive a timely diagnosis. In recent years, the imaging features and serologic biomarkers of pulmonary sarcoidosis have been continuously studied. The diagnostic value of imaging and serologic biomarkers for pulmonary sarcoidosis is summarized below.
摘要：
结节病是一种病因不明的多系统肉芽肿性疾病。它可以存在于许多器官中。肺和胸内淋巴结最常见。肺结节病在亚洲并不常见。然而,由于我国人口众多和支气管镜检查的发展，经皮肺穿刺,和其他医疗技术，肺结节病患者的数量正在上升。肺结节病患者早期无明显症状,后期的临床表现可能因人而异。最终,该疾病进展为危及生命的肺纤维化。因此,肺结节病患者应及时诊断。近年来,肺结节病的影像学特征和血清学生物标志物一直在研究。影像学和血清学生物标志物对肺结节病的诊断价值总结如下。
